
Milan J. Anadkat, M.D.
Assistant Professor of Dermatology
![]() |
Dr. Milan Anadkat is an Assistant Professor of Dermatology at Washington University School of Medicine. He graduated from the University of Akron and earned his medical degree at the Northeastern Ohio Universities College of Medicine. Dr. Anadkat performed his residency training at Washington University School of Medicine. He also completed a two-year clinical trials fellowship at Washington University School of Medicine.
In 2007, Dr. Anadkat joined the faculty of Washington University School of Medicine in St. Louis, MO as a Clinical Instructor of Dermatology. His clinical focus is in the area of medical dermatology: dermatologic therapeutics; psoriasis; collagen vascular disease; cutaneous lymphoma; autoimmune bullous disease; immunosuppression in the setting of organ-transplantation; graft-versus-host disease; and chemotherapy-induced adverse reactions.
Dr. Anadkat is a member of the American Academy of Dermatology, National Psoriasis Foundation, Medical Dermatology Society, Society for Investigative Dermatology, American Board of Dermatology, along with other professional organizations.
Dr. Anadkat’s publications include research papers, book chapters, scientific abstracts and clinical reviews.
Selected Publications
- Anadkat MJ, Cowen EW, Mercurio MG, Scott GA. Disseminated bullous fixed drug eruption caused by sympathomimetic medications: Ma huang, phenylpropanolamine, and pseudoephedrine. J Am Acad Dermatol. 2003 Nov; 49(5):E6.
- Heffernan MP, Anadkat MJ, Amin AN. PCL-016 gel (NV-02) in the treatment of acne vulgaris: a pilot study (abstract 337). J Invest Dermatol. 2004 Mar; 122(3):A57.
- Anadkat MJ, Tobler CE, Heffernan MP. Safety of imiquimod 5% cream in subjects with kidney or liver transplants (abstract 338). J Invest Dermatol. 2004 Mar; 122(3) A57.
- Heffernan MP, Anadkat MJ. Recalcitrant cutaneous sarcoidosis responding to infliximab. Arch Dermatol. 2005 Jul; 141(7): 910-1.

